US Physical Therapy (USPH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Apr, 2026Executive summary
The annual meeting is scheduled for May 19, 2026, to elect seven directors, approve executive compensation, and ratify the appointment of Grant Thornton LLP as auditor for 2026.
The board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.
Shareholders of record as of March 25, 2026, are entitled to vote, with one vote per share.
Voting matters and shareholder proposals
Proposals include election of seven directors, advisory approval of executive compensation, and ratification of Grant Thornton LLP as auditor.
The board recommends voting for all director nominees, executive compensation, and auditor ratification.
Shareholder proposals for the 2027 meeting must be submitted by February 18, 2027.
Board of directors and corporate governance
The board consists of a majority of independent directors, with Mr. Reading as Chairman/CEO and Dr. Harris as Lead Independent Director.
Four standing committees: Governance and Nominating, Compliance, Compensation, and Audit, all chaired by independent directors.
Board diversity is emphasized, with recent appointments increasing gender and ethnic diversity.
Directors are evaluated on experience, independence, and diversity; age limits apply for new and incumbent directors.
Latest events from US Physical Therapy
- Record 2025 growth and new alliances position for higher 2026 EBITDA and continued expansion.USPH
Q4 20259 Mar 2026 - Double-digit growth and high-margin expansion in injury prevention drive strong performance.USPH
16th Annual Midwest Ideas Conference3 Feb 2026 - Record patient volumes and IIP growth drove revenue up, but margins and EPS declined.USPH
Q2 20241 Feb 2026 - Growth continues via partnerships, acquisitions, and injury prevention despite reimbursement headwinds.USPH
15th Annual Midwest IDEAS Investor Conference23 Jan 2026 - Record patient volumes, 12% revenue growth, and major acquisitions drive future expansion.USPH
Q3 202416 Jan 2026 - Growth through strategic acquisitions and partnerships drives strong performance and expansion.USPH
2024 Southwest IDEAS Conference13 Jan 2026 - Record revenue and patient growth drive higher earnings and positive 2025 outlook.USPH
Q4 202430 Dec 2025 - Board recommends electing eight directors, approving executive pay, and ratifying auditor.USPH
Proxy Filing1 Dec 2025 - Record Q2 growth, raised 2025 guidance, and capital returns highlight strong performance.USPH
Q2 202523 Nov 2025